home / press / releases

Menu
  • Search all tables

releases: https://www.crapo.senate.gov/media/newsreleases/crapo-risch-colleagues-call-on-president-to-maintain-marijuana-as-schedule-i-drug

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://www.crapo.senate.gov/media/newsreleases/crapo-risch-colleagues-call-on-president-to-maintain-marijuana-as-schedule-i-drug Crapo, Risch, Colleagues Call on President to Maintain Marijuana as Schedule I Drug 2025-12-18 2025 2025-12 Republican Senate ID Mike Crapo C000880 www.crapo.senate.gov crapo https://www.crapo.senate.gov/media/newsreleases scraper Washington, D.C.--U.S. Senators Mike Crapo and Jim Risch (both R-Idaho) joined 20 of their Republican colleagues in sending a letter to President Donald Trump asking that marijuana remain a Schedule I drug. President Trump is expected to sign an executive order rescheduling marijuana to a Schedule III drug. “Rescheduling marijuana to a Schedule III drug will undermine your strong efforts to Make America Great Again and to usher in America’s next economic Golden Age. The only winners from rescheduling will be bad actors such as Communist China, while Americans will be left paying the bill,” wrote the Senators. Crapo and Risch are joined by U.S. Senators Ted Budd (R-North Carolina), Jim Banks (R-Indiana), John Barrasso (R-Wyoming), Marsha Blackburn (R-Tennessee), Shelley Moore Capito (R-West Virginia), Kevin Cramer (R-North Dakota), John Cornyn (R-Texas), Tom Cotton (R-Arkansas), Lindsey Graham (R-South Carolina), Bill Hagerty (R-Tennessee), Cindy Hyde-Smith (R-Mississippi), Ron Johnson (R-Wisconsin), James Lankford (R-Oklahoma), Cynthia Lummis (R-Wyoming), Roger Marshall (R-Kansas), Mitch McConnell (R-Kentucky), Dave McCormick (R-Pennsylvania), Pete Ricketts (R-Nebraska), Rick Scott (R-Florida) and Tommy Tuberville (R-Alabama). Marijuana is currently listed as a Schedule I drug or substance with a high potential for abuse and lacks Federal Drug Administration approval. In the letter, Senators outlined concerns with reclassifying marijuana to Schedule III, reserved for substances with moderate to low risk for physical and psychological dependence, including: The significant harm marijuana has on users, especially young people and pregnant or nursing women; Marijuana use causes impaired judgement, creating public safety risks on the roads and in workplaces; and The massive tax break marijuana companies will receive and use to market marijuana to kids. 1 2026-03-30T01:40:41Z 2026-04-06T20:09:11Z
Powered by Datasette · Queries took 0.894ms · Data license: MIT · Data source: dwillis/congress-press